Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells

被引:475
作者
Yamashita, S
Furubayashi, T
Kataoka, M
Sakane, T
Sezaki, H
Tokuda, H
机构
[1] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan
[2] Toko Pharmaceut, Kita Ku, Osaka 5310074, Japan
[3] Fujisawa Pharmaceut Co Ltd, Yodogawa Ku, Osaka 5328514, Japan
关键词
Caco-2; membrane permeability; intestinal absorption; medium pH; poorly soluble drugs; in vitro-in vivo correlation;
D O I
10.1016/S0928-0987(00)00076-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of various experimental conditions on in vitro drug permeability to Caco-2 monolayers were investigated to determine the optimized conditions for the prediction of intestinal drug absorption. Concerning the pH of the transport medium in the Caco-2 study, two different pH values, 6.0 and 7.4. were tested for the apical medium with the pH of the basolateral medium fixed to 7.4. The change in the apical pH showed pronounced effects on the permeability of both passively and actively transported drugs. It was found that the transport study under the condition of an apical pH value of 6.0 showed a better prediction of in vivo drug absorption in human. The appropriate conditions for determining the permeability of poorly soluble drugs were also examine. First, the effects of bile acids, surfactant and some agents used for solubilizing drugs on the permeability and transepithelial electrical resistance (TEER) of Caco-2 monolayers were investigated. Taurocholic and cholic acid showed no effects on the permeability of H-3-Dexamethasone (DEX) and TEER at 10 mM concentration, suggesting the possibility of use in the Caco-2 study. Polyethyleneglycol-400 and dimethylsulfoxide reduced the permeability of DES concentration dependently, whereas ethanol induced no significant changes in the permeability. Furthermore, it was demonstrated that the addition of plasma protein (bovine serum albumin) to the basolateral medium apparently facilitated the transport of poorly soluble drugs with high lipophilicity across Caco-2 monolayers. These findings clearly suggest the importance of considering the physiological conditions of in vivo drug absorption in optimizing the in vitro experimental conditions for transport study using Caco-2 cells, in order to obtain a satisfactory in vitro-in vivo correlation. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 38 条
[1]   ESTIMATING HUMAN ORAL FRACTION DOSE ABSORBED - A CORRELATION USING RAT INTESTINAL-MEMBRANE PERMEABILITY FOR PASSIVE AND CARRIER-MEDIATED COMPOUNDS [J].
AMIDON, GL ;
SINKO, PJ ;
FLEISHER, D .
PHARMACEUTICAL RESEARCH, 1988, 5 (10) :651-654
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[4]   COMMON CHARACTERISTICS FOR NA+-DEPENDENT SUGAR-TRANSPORT IN CACO-2 CELLS AND HUMAN-FETAL COLON [J].
BLAIS, A ;
BISSONNETTE, P ;
BERTELOOT, A .
JOURNAL OF MEMBRANE BIOLOGY, 1987, 99 (02) :113-125
[5]   MECHANISMS AND KINETICS OF UPTAKE AND EFFLUX OF L-METHIONINE IN AN INTESTINAL EPITHELIAL MODEL (CACO-2) [J].
CHEN, JY ;
ZHU, YP ;
HU, M .
JOURNAL OF NUTRITION, 1994, 124 (10) :1907-1916
[6]   In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system [J].
Chong, SH ;
Dando, SA ;
Soucek, KM ;
Morrison, RA .
PHARMACEUTICAL RESEARCH, 1996, 13 (01) :120-123
[7]   A MODEL OF HUMAN SMALL INTESTINAL ABSORPTIVE CELLS .1. TRANSPORT BARRIER [J].
COGBURN, JN ;
DONOVAN, MG ;
SCHASTEEN, CS .
PHARMACEUTICAL RESEARCH, 1991, 8 (02) :210-216
[8]   UPTAKE OF THE CEPHALOSPORIN, CEPHALEXIN, BY A DIPEPTIDE TRANSPORT CARRIER IN THE HUMAN INTESTINAL-CELL LINE, CACO-2 [J].
DANTZIG, AH ;
BERGIN, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1027 (03) :211-217
[9]  
Fisher JM, 1999, J PHARMACOL EXP THER, V289, P1143
[10]  
HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736